Werthenstein BioPharma GmbH

Swiss Biotech Association

Member

100% subsidiary of Merck & Co., Inc., USA. Process development and pilot manufacturing of biopharmaceuticals.

https://www.msd.ch
+41 41 499 97 97
wag.info@merck.com
Markus Tanner

Location

Industrie Nord 1, 6105 Schachen, Switzerland

Facts & figures

Type of organization

Private company
Year of foundation

1976
Number of employees in Switzerland

150-249

Key business

Core competencies

You may also be interested in

SIX

The Swiss Stock Exchange, representing more than a third of the European life sciences market capitalization and accounting for around 35% of the total market capitalization (as of 7 April 2021), the exchange is one of Europe’s leading listing venues for biotech companies.
Zürich

Laevoroc Oncology AG

Founded in 2019, Laevoroc is a privately-owned, Swiss oncology development group of companies with the vision to leverage ground-breaking technology to bring game-changing therapies to patients living with cancer.
Hünenberg

Rowestil Consulting GmbH

Expertise in exploratory clinical drug/diagnostic development is available across a number of disease areas. Timing of input into the developmental strategy from regulatory and commercial perspectives is important in moving development programs towards success.
6318 Walchwil